Odd-skipped related 1 plays a tumor suppressor role in ovarian cancer via promoting follistatin-like protein 1 transcription

[1]  K. Man,et al.  FSTL1 Secreted by Activated Fibroblasts Promotes Hepatocellular Carcinoma Metastasis and Stemness , 2021, Cancer Research.

[2]  Minfeng Chen,et al.  Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer , 2021, BMC Cancer.

[3]  Jing Ma,et al.  FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-κB pathway , 2021, Cancer Chemotherapy and Pharmacology.

[4]  N. Wu,et al.  FSTL1 promotes growth and metastasis in gastric cancer by activating AKT related pathway and predicts poor survival. , 2021, American journal of cancer research.

[5]  Yuan Wang,et al.  Reduced expression of odd-skipped related transcription factor 1 promotes proliferation and invasion of breast cancer cells and indicates poor patient prognosis , 2020, Oncology letters.

[6]  Zheng Jiang,et al.  Downregulation of OSR1 Promotes Colon Adenocarcinoma Progression via FAK-Mediated Akt and MAPK Signaling , 2020, OncoTargets and therapy.

[7]  Q. Shen,et al.  Exploring cisplatin resistance in ovarian cancer through integrated bioinformatics approach and overcoming chemoresistance with sanguinarine. , 2020, American journal of translational research.

[8]  M. Hsiao,et al.  Follistatin-like protein 1 inhibits lung cancer metastasis by preventing proteolytic activation of osteopontin. , 2019, Cancer research.

[9]  A. Oza,et al.  Epithelial ovarian cancer: Evolution of management in the era of precision medicine , 2019, CA: a cancer journal for clinicians.

[10]  F. Yao,et al.  Corrigendum to "Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-κB pathway" [Eur. J. Pharmacol. 15 (2018) 33-39]. , 2019, European Journal of Pharmacology.

[11]  F. Yao,et al.  Odd‐skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF‐&kgr;B pathway , 2018, European journal of pharmacology.

[12]  A. Jemal,et al.  Ovarian cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[13]  Zhi-yan Hu,et al.  FSTL1 interacts with VIM and promotes colorectal cancer metastasis via activating the focal adhesion signalling pathway , 2018, Cell Death & Disease.

[14]  Y. Wang,et al.  Odd‐skipped related 1 inhibits lung cancer proliferation and invasion by reducing Wnt signaling through the suppression of SOX9 and β‐catenin , 2018, Cancer science.

[15]  M. V. D. van den Hoff,et al.  Follistatin-like 1 in development and human diseases , 2018, Cellular and Molecular Life Sciences.

[16]  G. Cao,et al.  Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma , 2018, Chinese journal of cancer.

[17]  G. Pados,et al.  Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers , 2017, Carcinogenesis.

[18]  Yongquan Wu,et al.  FSTL1 suppresses tumor cell proliferation, invasion and survival in non-small cell lung cancer , 2017, Oncology reports.

[19]  K. Chan,et al.  FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma through NFκB-BMP Signaling Cross-talk. , 2017, Cancer research.

[20]  B. Timmermann,et al.  Odd skipped-related 1 identifies a population of embryonic fibro-adipogenic progenitors regulating myogenesis during limb development , 2017, Nature Communications.

[21]  Min Liu,et al.  Effects of FSTL1 on the proliferation and motility of breast cancer cells and vascular endothelial cells , 2017, Thoracic cancer.

[22]  P. Chaturvedi,et al.  Identification of Osr2 Transcriptional Target Genes in Palate Development , 2017, Journal of dental research.

[23]  F. Abdul-Karim,et al.  Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer , 2017, Breast Cancer Research.

[24]  Yingduan Cheng,et al.  OSR1 is a novel epigenetic silenced tumor suppressor regulating invasion and proliferation in renal cell carcinoma , 2017, Oncotarget.

[25]  L. Jones,et al.  A holistic approach to dissecting SPARC family protein complexity reveals FSTL-1 as an inhibitor of pancreatic cancer cell growth , 2016, Scientific Reports.

[26]  Stephen T. C. Wong,et al.  Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis. , 2015, American journal of physiology. Cell physiology.

[27]  Jun Yu,et al.  Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer , 2014, The Journal of pathology.

[28]  N. Hukriede,et al.  osr1 is required for podocyte development downstream of wt1a. , 2014, Journal of the American Society of Nephrology : JASN.

[29]  Han Liu,et al.  Odd-skipped related-1 controls neural crest chondrogenesis during tongue development , 2013, Proceedings of the National Academy of Sciences.

[30]  A. G. de Herreros,et al.  Proteome Profiling of Cancer-Associated Fibroblasts Identifies Novel Proinflammatory Signatures and Prognostic Markers for Colorectal Cancer , 2013, Clinical Cancer Research.

[31]  P. Ip,et al.  Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis: a differential expression and functional analysis. , 2009, Carcinogenesis.

[32]  S. Orsulic,et al.  Ovarian Cancer , 1993, British Journal of Cancer.